Cavernous LymphangiomaSymptoms, Doctors, Treatments, Advances & More
Cavernous Lymphangioma Overview
Learn About Cavernous Lymphangioma
Center For Complex Obstetric Medicine
Mary Norton is a Neonatologist and a Medical Genetics provider practicing medicine in San Francisco, California. Dr. Norton is rated as a Distinguished provider by MediFind in the treatment of Cavernous Lymphangioma. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Fetal Edema, Hydrops Fetalis, Alpha Thalassemia, and Hemolytic Disease of the Newborn. Dr. Norton is board certified in American Board Of Obstetrics And Gynecology, Obstetrics & Gynecology, American Board Of Medical Genetics And Genomics, Clinical Genetics And Genomics, and American Board Of Obstetrics And Gynecology, Maternal-Fetal Medicine. Dr. Norton is currently accepting new patients.
Maternal-Fetal Medicine
Jessica Scholl is a Neonatologist and an Obstetrics and Gynecologist practicing medicine in New York, New York. Dr. Scholl is rated as an Elite provider by MediFind in the treatment of Cavernous Lymphangioma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Cavernous Lymphangioma, Fetal Edema, Hydrops Fetalis, and Hemolytic Disease of the Newborn. Dr. Scholl is currently accepting new patients.
Chih-ping Chen practices practicing medicine in Taiwan. Chen is rated as an Elite expert by MediFind in the treatment of Cavernous Lymphangioma. They are also highly rated in 124 other conditions, according to our data. Their clinical expertise encompasses Trisomy 14 Mosaicism, Mosaicism, Trisomy 2 Mosaicism, and Chromosome 13q Duplication.
Summary: Recent studies have demonstrated that growth of vascular malformations can be driven by genetic variants in one of 2 signalling pathways. Targeted drugs specific to these pathways have been developed and shown to be effective in treating cancer. This study will describe the effectiveness of (i) 48 weeks of alpelisib therapy for participants with slow-flow vascular malformations and a gene mutation...
Summary: Lymphatic malformations (ML), are benign non-neoplastic, rare, resulting from an embryologic abnormal development of the lymphatic system. Sometimes they may be associated with other vascular malformations (venous or arterial)1,2. ML usually appear at birth, in early childhood or during the first years of life (congenital vs. acquired) and are mainly localized in the region of the head and neck, a...
